Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × COVID-19 × 30 days × Clear all

Phase

Status

Sponsor Class

OTHER 5 NIH 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 222 Neoplasms 134 Breast Neoplasms 130 Colorectal Neoplasms 93 Prostatic Neoplasms 89 Neoplasm Metastasis 82 Ovarian Neoplasms 81 Multiple Myeloma 73 Melanoma 67 Lung Neoplasms 64 Endometrial Neoplasms 58 Recurrence 56 Stomach Neoplasms 53 Squamous Cell Carcinoma of Head and Neck 49 Pancreatic Neoplasms 48 Triple Negative Breast Neoplasms 44 Leukemia, Lymphocytic, Chronic, B-Cell 44 Leukemia, Myeloid, Acute 43 Lymphoma, Non-Hodgkin 42 Small Cell Lung Carcinoma 41 Lymphoma, Follicular 40 Lymphoma, Large B-Cell, Diffuse 37 Parkinson Disease 4, Autosomal Dominant Lewy Body 36 Carcinoma, Renal Cell 36 Uterine Cervical Neoplasms 33 Urinary Bladder Neoplasms 32 Myasthenia Gravis 31 Lymphoma 30 Carcinoma, Hepatocellular 30 Glioblastoma 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07450833 2026-03-05

BOOST

Benfovir AG

Phase 1 Completed

COVID-19, Neoplasms, Korsakoff Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡